W hen it comes to the best Christmas tree themes, we like to live by the motto “The more, the merrier!” And Christmas trends ...

Easy to grow and guaranteed to add bursts of showy blossoms to any garden, gladiolus flowers, classic summer bloomers, are ...

It’s a tough pill to swallow but every mom has to come to terms with the fact that, eventually, your bitty baby will grow up ...

Have you noticed your little one is not so little anymore? Is he outgrowing his crib — or even looking a little scrunched in ...

We’ve sifted through Black Friday perfume deals to put together advice on how to find discounts on big brands such as Miss ...

JOHN Lewis’ annual Christmas advert is set to land tomorrow and excitement is already building. The retailer’s advert is ...

The new PDX store sells authentic cards for all occasions, alongside airport staples like pens and neck pillows.

Big Brother viewers have furiously slammed the show's final twist after it was teased during spin-off Late And Live on Sunday ...

Right now, Eli Lilly dominates the weight loss industry thanks to its dual agonists Mounjaro and Zepbound. Viking Therapeutics is a clinical-stage biotech that's looking to compete with Lilly in ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from the SUMMIT Phase 3 trial showing tirzepatide significantly reduced the risk of worsening heart failure events in adults with ...

Eli Lilly and Company (NYSE: LLY) announced today detailed results from the Phase 3 SURMOUNT-1 three-year study (176-week treatment period), the longest completed study to date of tirzepatide.

Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges, including obesity. The proposal ...